Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mediator of RNA polymerase II transcription subunit 31 (MED31) is a highly conserved subunit of the Mediator complex, a multiprotein complex that functions as a central scaffold and transcriptional coactivator in the regulated transcription of nearly all RNA polymerase II-dependent genes[3][4][5]. MED31 is essential in bridging gene-specific regulatory proteins to the basal transcription machinery, facilitating the assembly of a functional preinitiation complex with RNA polymerase II and general transcription factors[3][4]. MED31’s functions include regulation of transcription, limb development, and negative regulation of fibroblast proliferation[3][5]. It is encoded by the MED31 gene in humans and is homologous to yeast SOH1[5]. MED31 is not currently classified as a direct therapeutic target, receptor, enzyme, or transporter, and there are no known interacting drugs or mechanisms of action established for clinical therapeutics[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mediator of RNA polymerase II transcription subunit 31 (MED31).